Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depot

European Journal of Endocrinology

Volumn 159, Issue 6, 2008, Pages 713-718

  Wang, Ping ^a   Smit, Egbert ^a   Brouwers, Martijn C G J ^b   Goossens, Gijs H ^a   van der Kallen, Carla J H ^b   van Greevenbroek, Marleen M J ^b   Mariman, Edwin C M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; GLUCOSE; INSULIN; LIPID; PIGMENT EPITHELIUM DERIVED FACTOR; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGE; ANTHROPOMETRY; ARTICLE; BODY MASS; CAUCASIAN; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEIN SECRETION; SEX DIFFERENCE; ABDOMINAL SUBCUTANEOUS FAT; AGED; BLOOD; BODY FAT DISTRIBUTION; COMPARATIVE STUDY; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BODY FAT DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; EYE PROTEINS; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; OBESITY; SERPINS; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 58149357552     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0521     Document Type: Article

References (32)

1. Caballero AE. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obesity Research 2003 11 1278-1289.
2. Calle EE, Rodriguez C, Walker-Thurmond K & Thun MJ. Over-weight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine 2003 348 1625-1638.
3. Wang P, Mariman E, Renes J & Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. Journal of Cellular Physiology 2008 216 3-13.
4. Ailhaud G. Adipose tissue as a secrctory organ: from adipogenesis to the metabolic syndrome. Comptes Rendus Biologies 2006 329 570-577.
5. Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, Robben J & Renes J. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cellular and Molecular Life Sciences 2004 61 2405-2417.
6. Tombran-Tink J, Chader GG & Johnson LV. PEDF: a pigment epithelium-derived factor with potent ncuronal differentiative activity. Experimental Eye Research 1991 53 411-414.
7. Chader GJ. Surmountable challenges in translating pigment epithelium-derived factor (PEDF) therapy from animal models to clinical trials for retinal degenerations. Retina 2005 25 S29-S30.
8. Fernandez-Garcia NI, Volpert OV & Jimenez B. Pigment epithelium-derived factor as a multifunctional antitumor factor. Journal of Molecular Medicine 2007 85 15-22.
9. Notari L, Baladron V, Aroca-Aguilar JD, Balko N, Heredia R, Meyer C, Notario PM, Saravanamuthu S, Nueda ML, Sanchez-Sanchez F, Escribano J, Laborda J & Becerra SP. Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. Journal of Biological Chemistry 2006 281 38022-38037.
10. Arner P & Langin D. The role of neutral lipases in human adipose tissue lipolysis. Current Opinion in Lipidology 2007 18 246-250.
11. Zimmermann R, Strauss IG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A & Zechner R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004 306 1383-1386.
12. Chung C, Doll JA, Gattu AK, Shugrue C, Cornwell M, Fitchev P & Crawford SE. Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). Journal of Hepatology 2008 48 471-478.
13. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR & Hogenesch JB. A gene atlas of the mouse and human protein-encoding transcriptomes. PNAS 2004 101 6062-6067.
14. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y & Matsubara K. Analysis of an expression profile of genes in the human adipose tissue. Gene 1997 190 227-235.
15. Zvonic S, Lefevre M, Kilroy G, Floyd ZE, DeLany JP, Kheterpal I, Gravois A, Dow R, White A, Wu X & Gimble JM. Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Molecular and Cellular Proteomics 2007 6 18-28.
16. Yamagishi S, Adachi H, Abe A, Yashiro T, Enomoto M, Furuki K, Hino A, Jinnouchi Y, Takenaka K, Matsui T, Nakamura K & Imaizumi T. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2006 91 2447-2450.
17. Wang P, van Greevenbroek MM, Bouwman FG, Brouwers MC, van der Kallen CJ, Smit E, Keijer J & Mariman EC. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflügers Archiv 2007 454 971-976.
18. Brouwers MC, Bilderbeek-Beckers MA, Georgieva AM, van der Kallen CJ, van Greevenbroek MM & de Bruin TW. Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids. Clinical Science 2007 112 123-130.
19. Keulen ET, Voors-Pette C & de Bruin TW. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass. American Journal of Hypertension 2001 14 357-363.
20. Durnin JV & Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. British Journal of Nutrition 1974 32 77-97.
21. Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP & Grobbee DE. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. International Journal of Obesity and Related Metabolic Disorders 2001 25 1346-1351.
22. van der Kallen CJ, Voors-Pette C, Bouwman PG, Keizer HA, Lu JY, van de Hulst RR, Bianchi R, Janssen MJ, Keulen ET. Boeckx WD, Rotter JI & de Bruin TW. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus. Atherosclerosis 2002 164 337-346.
23. Brouwers MC, Cantor RM, Kono N, Yoon JL, van der Kallen CJ, Bilderbeek-Beckers MA, van Greevenbroek MM, Lusis AJ & de Bruin TW. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia. Journal of Lipid Research 2006 47 2799-2807.
24. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Hakkinen AM, Fredriksson J & Yki-Jarvinen H. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004 47 1360-1369.
25. Wheeler DL, Church DM, Federhen S, Lash AE, Madden TL, Pontius JU, Schuler GD, Schriml LM, Sequeira E, Tatusova TA & Wagner L. Database resources of the National Center for Biotechnology. Nucleic Acids Research 2003 31 28-33.
26. Steinberg GR, Kemp BE & Watt MJ. Adipocyte triglyceride lipase expression in human obesity. American Journal of Physiology. Endocrinology and Metabolism 2007 293 E958-E964.
27. Jakobsen MU, Berentzen T, Sorensen TI & Overvad K. Abdominal obesity and fatty liver. Epidemiologic Reviews 2007 29 77-87.
28. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Annals of Medicine 2006 38 52-63.
29. Sarafidis PA & Nilsson PM. The metabolic syndrome: a glance at its history. Journal of Hypertension 2006 24 621-626.
30. Kahn R, Buse J, Ferrannini E & Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005 28 2289-2304.
31. Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL, Chung JS, O'Neal DN, Januszewski AS, Croft KD, Mori TA, Dragicevic G, Harper CA, Best JD, Lyons TJ & Ma JX. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes. Diabetic Medicine 2007 24 1345-1351.
32. Ogata N, Matsuoka M, Matsuyama K, Shima C, Tajika A, Nishiyama T, Wada M, Jo N, Higuchi A, Minamino K, Matsunaga H, Takeda T & Matsumura M. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. Journal of Clinical Endocrinology and Metabolism 2007 92 1176-1179.